Legionnaires’ disease in Switzerland: Rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO)
View ORCID ProfileFabienne B. Fischer, View ORCID ProfileMelina Bigler, View ORCID ProfileDaniel Mäusezahl, Jan Hattendorf, View ORCID ProfileAdrian Egli, View ORCID ProfileTimothy R. Julian, Franziska Rölli, Valeria Gaia, Monica Wymann, Françoise Fridez, Stefanie Bertschi, the SwissLEGIO Hospital Network
doi: https://doi.org/10.1101/2022.10.21.21265377
Fabienne B. Fischer
1Swiss Tropical and Public Health Institute, Allschwil, Switzerland
2University of Basel, Basel, Switzerland
Melina Bigler
1Swiss Tropical and Public Health Institute, Allschwil, Switzerland
2University of Basel, Basel, Switzerland
Daniel Mäusezahl
1Swiss Tropical and Public Health Institute, Allschwil, Switzerland
2University of Basel, Basel, Switzerland
Jan Hattendorf
1Swiss Tropical and Public Health Institute, Allschwil, Switzerland
2University of Basel, Basel, Switzerland
Adrian Egli
3Institute for Medical Microbiology, University of Zurich, Zürich, Switzerland
Timothy R. Julian
1Swiss Tropical and Public Health Institute, Allschwil, Switzerland
2University of Basel, Basel, Switzerland
4Eawag, Swiss Federal Institute of Aquatic Science and Technology, Dübendorf, Switzerland
Franziska Rölli
5Lucerne University of Applied Sciences and Arts, Luzern, Switzerland
Valeria Gaia
6National Reference Centre for Legionella, Service of microbiology, Institute of laboratory medicine, EOC, Bellinzona, Switzerland
Monica Wymann
7Federal Office of Public Health, Bern, Switzerland
Françoise Fridez
8Federal Food Safety and Veterinary Office, Bern, Switzerland
Stefanie Bertschi
9Swiss Federal Office of Energy, Bern, Switzerland

Article usage
Posted October 22, 2022.
Legionnaires’ disease in Switzerland: Rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO)
Fabienne B. Fischer, Melina Bigler, Daniel Mäusezahl, Jan Hattendorf, Adrian Egli, Timothy R. Julian, Franziska Rölli, Valeria Gaia, Monica Wymann, Françoise Fridez, Stefanie Bertschi, the SwissLEGIO Hospital Network
medRxiv 2022.10.21.21265377; doi: https://doi.org/10.1101/2022.10.21.21265377
Legionnaires’ disease in Switzerland: Rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO)
Fabienne B. Fischer, Melina Bigler, Daniel Mäusezahl, Jan Hattendorf, Adrian Egli, Timothy R. Julian, Franziska Rölli, Valeria Gaia, Monica Wymann, Françoise Fridez, Stefanie Bertschi, the SwissLEGIO Hospital Network
medRxiv 2022.10.21.21265377; doi: https://doi.org/10.1101/2022.10.21.21265377
Subject Area
Subject Areas
- Addiction Medicine (269)
- Allergy and Immunology (549)
- Anesthesia (135)
- Cardiovascular Medicine (1748)
- Dermatology (172)
- Emergency Medicine (310)
- Epidemiology (10785)
- Gastroenterology (584)
- Genetic and Genomic Medicine (2935)
- Geriatric Medicine (286)
- Health Economics (531)
- Health Informatics (1919)
- Health Policy (833)
- Hematology (290)
- HIV/AIDS (627)
- Medical Education (299)
- Medical Ethics (86)
- Nephrology (321)
- Neurology (2783)
- Nursing (150)
- Nutrition (431)
- Oncology (1457)
- Ophthalmology (441)
- Orthopedics (172)
- Otolaryngology (255)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (380)
- Pediatrics (865)
- Primary Care Research (334)
- Public and Global Health (5342)
- Radiology and Imaging (1004)
- Respiratory Medicine (724)
- Rheumatology (329)
- Sports Medicine (278)
- Surgery (327)
- Toxicology (47)
- Transplantation (149)
- Urology (125)